UCLA to lead CDC-funded study on effectiveness of vaccines among health workers

The  David Geffen School of Medicine at UCLA has received a $4.9 million grant from the Centers for Disease Control and Prevention to study the effectiveness of COVID-19 vaccines among health care workers.The yearlong project,Preventing Emerging Infections through Vaccine Effectiveness Testing, or PREVENT,  will be conducted with the University of Iowa ’s Carver College of Medicine and will enroll 10,000 health care personnel at 16 academic medical centers across the county, including Olive View–UCLA Medical Center in Sylmar, California. Researchers will study both vaccinated and non-vaccinated health care workers who get tested for the virus after experiencing common COVID-19 symptoms like fever, cough or a loss of sense of taste or smell. The study will compare the incidence of positive COVID-19 tests among both groups, as well as the severity of the illness in those who test positive. The results will help researchers determine how effective the vaccines are at preventing infection and lessening the impact of infections when they do occur.Dr. David Talan, a professor of emergency medicine and of medicine and infectious diseases in the UCLA Department of Emergency Medicine, will lead the trial with co-principal investigator Dr. Nicholas Mohr, a professor of emergency medicine, anesthesia and epidemiology at the University of Iowa.“Health care workers all across the world have stepped up to meet the overwhelming needs of patients, families and communities during th...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news